Riboflavin offers a targeted strategy for managing hypertension in patients with the MTHFR 677TT genotype: a 4-y follow-up.


Abstract

Optimizing riboflavin status offers a low-cost targeted strategy for managing elevated BP in this genetically at-risk group.

These findings, if confirmed in the general population, could have important implications for the prevention of hypertension.


Full Text


Subjects


Similar articles

Español | English

© Galenicom 1999-2013